“HIGH-RISK” HOST CELL PROTEINS (HCPs): A MULTI-COMPANY COLLABORATIVE VIEW

生物制药 担心 业务 质量(理念) 产品(数学) 新产品开发 风险分析(工程) 营销 生物技术 心理学 生物 哲学 精神科 认识论 焦虑 数学 几何学
作者
Marisa Jones,Nisha Palackal,Fengqiang Wang,Georgeen Gaza‐Bulseco,Karen Hurkmans,Yiwei Zhao,Carmelata Chitikila,Séverine Clavier,Suli Liu,Emily Menesale,Nicole S. Schonenbach,Satish Kumar Sharma,Thomas Waerner,Lei Zhang,Patricia Connolly
出处
期刊:Authorea - Authorea 被引量:1
标识
DOI:10.22541/au.160266604.42218591/v1
摘要

Host cell proteins (HCPs) are process-related impurities that may co-purify with biopharmaceutical drug products. Within this class of impurities there are some that are more problematic. These problematic HCPs can be considered high-risk and can include those that are immunogenic, biologically active, or enzymatically active with the potential to degrade either product molecules or excipients used in formulation, and often are difficult-to-purify. Why should the biopharmaceutical industry worry about these high-risk host cell proteins? What approach could be taken to understand the origin of this co-purification and to deal with these high-risk HCPs? To answer these questions, the BioPhorum Development Group (BPDG) HCP Workstream initiated a collaboration among its 26-company team with the goal of industry alignment around high-risk HCPs. A sub team was formed, in which the members performed literature searches and discussed the information available around this topic. A survey to the BPDG HCP Workstream team members led to team discussions and insights into a list of frequently seen problematic HCPs. These HCPs were further classified based on their potential impact into different risk categories that could be beneficial to the biopharmaceutical industry for targeted monitoring of those HCP impurities in CHO-produced biologics to minimize risk to product quality, safety, and efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
共享精神应助科研通管家采纳,获得10
刚刚
1秒前
jeff完成签到,获得积分10
2秒前
merrylake完成签到 ,获得积分10
3秒前
Kong完成签到,获得积分10
4秒前
eric888应助小趴菜采纳,获得200
4秒前
5秒前
ZHANGXUEJUN完成签到,获得积分10
5秒前
蔡从安发布了新的文献求助10
5秒前
burn完成签到,获得积分10
5秒前
muzi完成签到,获得积分10
6秒前
chao完成签到,获得积分10
7秒前
day_on发布了新的文献求助10
8秒前
一一完成签到,获得积分10
9秒前
orixero应助Champ采纳,获得10
9秒前
一点完成签到 ,获得积分0
9秒前
ZYN完成签到 ,获得积分10
11秒前
搜集达人应助永远的阿科采纳,获得20
12秒前
SYLH应助蔡从安采纳,获得10
12秒前
14秒前
照镜子丫dorime完成签到,获得积分10
16秒前
奉雨眠完成签到,获得积分10
16秒前
埋头苦干科研完成签到,获得积分10
17秒前
闫栋完成签到 ,获得积分10
17秒前
稳重的秋天完成签到,获得积分20
19秒前
19秒前
坐雨赏花完成签到 ,获得积分10
19秒前
文献狗完成签到,获得积分10
19秒前
DMMM完成签到,获得积分10
20秒前
day_on完成签到,获得积分10
20秒前
车非笑完成签到,获得积分10
20秒前
21秒前
玛卡巴卡发布了新的文献求助10
21秒前
王二哈完成签到,获得积分10
22秒前
芝麻福福完成签到,获得积分10
22秒前
曼夭非夭完成签到,获得积分10
23秒前
wang完成签到,获得积分10
24秒前
xue完成签到 ,获得积分10
24秒前
zhang完成签到,获得积分10
25秒前
25秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Residual Stress Measurement by X-Ray Diffraction, 2003 Edition HS-784/2003 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950021
求助须知:如何正确求助?哪些是违规求助? 3495348
关于积分的说明 11076451
捐赠科研通 3225877
什么是DOI,文献DOI怎么找? 1783346
邀请新用户注册赠送积分活动 867596
科研通“疑难数据库(出版商)”最低求助积分说明 800839